COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY

The present invention provides compounds and methods for the treatment of diabetic retinopathy. In particular, LFA-I antagonists are described herein to be used in the treatment of diabetic retinopathy. One aspect of the invention provides for diagnosis of diabetic retinopathy and administration of...

Full description

Saved in:
Bibliographic Details
Main Authors GADEK, THOMAS, SEMBA, CHARLES, BURNIER, JOHN
Format Patent
LanguageEnglish
French
Published 11.04.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides compounds and methods for the treatment of diabetic retinopathy. In particular, LFA-I antagonists are described herein to be used in the treatment of diabetic retinopathy. One aspect of the invention provides for diagnosis of diabetic retinopathy and administration of a LFA-I antagonist, after the patient is diagnosed with diabetic retinopathy. Cette invention concerne des composés et des procédés pour le traitement de la rétinopathie diabétique. En particulier, l'invention concerne des antagonistes LFA-I à utiliser dans le traitement de la rétinopathie diabétique. Un aspect de l'invention concerne le diagnostic de la rétinopathie diabétique et l'administration d'un antagoniste LFA-I, après que le patient est diagnostiqué comme porteur d'une rétinopathie diabétique.
Bibliography:Application Number: CA20082702984